GHO Capital, a private equity firm, completed the acquisition of Ardena, a specialist contract development and manufacturing organization focused on early phase drug development, from Mentha Capital. Financial terms were not disclosed. “Ardena has grown from a Ghent-based business to become a leading early-stage, multi-service CDMO in Western Europe. After successfully completing and integrating four acquisitions, the company is now ready for a new growth phase. We had a fantastic journey with the Ardena team, and we are confident that GHO Capital is the right partner to support their ambitions going forward,” Gijs Botman, Mentha Capital Partner.